Valuation : Theraclion

Market Cap 5.12Cr 5.95Cr 4.82Cr 4.39Cr 8.21Cr 565.91Cr 8.25Cr 57Cr 22Cr 0 22Cr 22Cr 913.36Cr P/E 2024
-2.66x
P/E 2025 -6.33x
Enterprise Value 5.9Cr 6.86Cr 5.56Cr 5.06Cr 9.48Cr 652.74Cr 9.51Cr 66Cr 25Cr 0 26Cr 25Cr 1.05TCr EV / Sales 2024
22.5x
EV / Sales 2025 55.4x
Free-Float
39.01%
Yield 2024 *
-
Yield 2025 -
1 day-2.00%
1 week-6.28%
Current month-8.53%
1 month+15.49%
3 months-9.50%
6 months+24.73%
Current year+13.95%
1 week 0.67
Extreme 0.67
0.75
1 month 0.59
Extreme 0.593
0.8
Current year 0.4
Extreme 0.402
0.93
1 year 0.4
Extreme 0.402
1.25
3 years 0.14
Extreme 0.1416
1.25
5 years 0.14
Extreme 0.1416
2.22
10 years 0.14
Extreme 0.1416
6.3
Manager TitleAgeSince
Chief Executive Officer - 24/05/2023
Director of Finance/CFO - -
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member - 22/06/2021
Director/Board Member - 28/01/2022
Director/Board Member - 29/06/2023
Date Insider Type Main position Quantity % Market Cap. Importance
26/08/26 Exercice

Director

2,66,139 0.3627%
Change 5-day change 1-year change 3-year change Capi.($)
-2.00%-6.28%-4.46%+12.09% 5.95Cr
-0.70%-2.56%+26.46%+17.03% 22TCr
-1.30%-4.18%+4.99%-19.17% 14TCr
+2.02%-2.58%-19.93%+19.16% 12TCr
-2.05%-6.36%-58.22%-19.42% 6.52TCr
-0.70%-1.00%-20.42%-15.11% 5TCr
+0.44%-3.50%+10.67%+15.71% 4.97TCr
-1.03%-4.41%+15.51%+26.76% 4.08TCr
-0.77%-2.85%+37.11%+52.59% 3.98TCr
-0.79%-8.17%+113.17%+31.54% 3.1TCr
Average -0.70%-1.81%+10.49%+12.12% 7.69TCr
Weighted average by Cap. -0.45%-2.29%+7.13%+8.27%

Financials

2024 2025
Net sales 8L 10L 8L 7L 13.33L 9.18Cr 13.38L 92.65L 35.81L 0 36.23L 35.44L 15Cr 7L 8L 6L 6L 10.47L 7.21Cr 10.51L 72.76L 28.12L 0 28.45L 27.83L 12Cr
Net income -57.57L -66.9L -54.21L -49.39L -92.41L -64Cr -92.78L -6.42Cr -2.48Cr -0 -2.51Cr -2.46Cr -102.75Cr -56.9L -66.12L -53.58L -48.82L -91.34L -63Cr -91.7L -6.35Cr -2.45Cr -0 -2.48Cr -2.43Cr -101.55Cr
Net Debt 34.11L 39.64L 32.12L 29.26L 54.75L 38Cr 54.97L 3.81Cr 1.47Cr 0 1.49Cr 1.46Cr 61Cr 78.52L 91.25L 73.93L 67.37L 1.26Cr 87Cr 1.27Cr 8.76Cr 3.39Cr 0 3.43Cr 3.35Cr 140.14Cr
Logo Theraclion
Theraclion specializes in developping, manufacturing and marketing echotherapy equipment associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules.Net sales break down by activity as follows: - sale of consumables (52.8%); - sale of equipment (28.8%); - provision of after-sales services (18.4%). The vast majority of net sales are earned abroad.
Employees
36
Date Price Change Volume
10/26/10 0.6860 -2.00% 40,299
09/26/09 €0.7000 +2.19% 42,969
08/26/08 €0.6850 -1.30% 19,120
07/26/07 €0.6940 -5.19% 49,171
04/26/04 €0.7320 0.00% 1,75,499

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALTHE Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!